Economic burden of osteoporotic fractures in Austria

Health Economics Review

Volumn 2, Issue 1, 2012, Pages 1-10

  Dimai, Hans Peter ^a   Redlich, Kurt ^b   Peretz, Monika ^c   Borgström, Fredrik ^d,e   Siebert, Uwe ^f   Mahlich, Jörg ^g  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Association for the Promotion of Continuing Medical Education and Research   (Austria)

^d i3 Innovus   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

^f UNIVERSITY FOR HEALTH SCIENCES   (Austria)

^g UNIVERSITY OF VIENNA   (Austria)

Author keywords

Austria; Burden of illness; Costs of illness; Osteoporosis

Indexed keywords

ALENDRONIC ACID; ALENDRONSTAD; ANALGESIC AGENT; CAL D VITA; CALCITONIN; CALCIUM; DICLOFENAC; IBANDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; RALOXIFENE; RECOMBINANT PARATHYROID HORMONE; RISEDRONIC ACID; STRONTIUM RANELATE; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

ABSENTEEISM; ARTICLE; AUSTRIA; COST OF ILLNESS; DRUG COST; FINANCIAL INFORMATION SYSTEM; FOREARM FRACTURE; FRAGILITY FRACTURE; HEALTH CARE MANAGEMENT; HEALTH CARE UTILIZATION; HEALTH SERVICE; HIP FRACTURE; HOSPITALIZATION COST; HUMAN; HUMERUS FRACTURE; LENGTH OF STAY; MEDICAL FEE; MEDICAL LEAVE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; QUALITY OF LIFE; RETIREMENT; RIB FRACTURE; SPINE FRACTURE;

EID: 84971350008     PISSN: None     EISSN: 21911991     Source Type: Journal    
DOI: 10.1186/2191-1991-2-12     Document Type: Article

References (40)

1. Consensus development conference: prophylaxis and treatment of osteoporosis. Am J Med 1991, 90(1):107-110.
2. Johnell O, Kanis J: Epidemiology of osteoporotic fractures. Osteoporos Int 2005, 16(2):S3-S7.
3. Cooper C, Cole ZA, Holroyd CR, Earl SC, Harvey NC, Dennison EM, et al: Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int 2011, 22(5):1277-1288.
4. Johnell O, Kanis JA: An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006, 17(12):1726-1733.
5. Cummings SR, Melton LJ: Epidemiology and outcomes of osteoporotic fractures. Lancet 2002, 359(9319):1761-1767.
6. Ben Sedrine W, Radican L, Reginster JY: On conducting burden-of-osteoporosis studies: a review of the core concepts and practical issues. A study carried out under the auspices of a WHO Collaborating Center. Rheumatology (Oxford) 2001, 40(1):7-14.
7. Lippuner K, Golder M, Greiner R: Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland. Osteoporos Int 2005, 16(Suppl 2):S8-S17.
8. Gabriel SE, Tosteson ANA, Leibson CL, Crowson CS, Pond GR, Hammond CS, et al: Direct medical costs attributable to osteoporotic fractures. Osteoporos Int 2002, 13(4):323-330.
9. Wiktorowicz ME, Goeree R, Papaioannou A, Adachi JD, Papadimitropoulos E: Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 2001, 12(4):271-278.
10. Reginster JY, Gillet P, Ben Sedrine W, Brands G, Ethgen O, de Froidmont C, et al: Direct costs of hip fractures in patients over 60 years of age in Belgium. Pharmacoeconomics 1999, 15(5):507-514.
11. Brecht J, Schdlich P: Burden of illness imposed by osteoporosis in Germany. HEPAC Health Economics in Prevention and Care 2000, 1(1):26.
12. Häussler B, Gothe H, Göl D, Glaeske G, Pientka L, Felsenberg D: Epidemiology, treatment and costs of osteoporosis in Germany-the BoneEVA Study. Osteoporos Int 2007, 18(1):77-84.
13. Dimai HP, Svedbom A, Fahrleitner-Pammer A, Pieber T, Resch H, Zwettler E, et al: Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int 2011, 22(2):685-692.
14. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programs. 3rd edition. Oxford: Oxford University Press; 2005.
15. Johannesson M, Karlsson G: The friction cost method: a comment. J Health Econ 1997, 16(2):249-255.
16. Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B: Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 2004, 15(2):108-112.
17. Garraway WM, Stauffer RN, Kurland LT, O'Fallon WM: Limb fractures in a defined population.II. Orthopedic treatment and utilization of health care. Mayo Clin Proc 1979, 54(11):708-713.
18. Arden N, Cooper Meunier P, Future of osteoporosis: Epidemiology. In Osteoporosis. Edited by Diagnosis and Management. 1998.
19. Neill D, Hughes D, Leake A, Morris C, Jones D, Oakley A, et al: Neuritogenic-neurotoxic effects of membrane-associated forms of amyloid precursor protein. Dement Geriatr Cogn Disord 2001, 12(1):40-51.
20. Palvanen M, Kannus P, Niemi S, Parkkari J: Hospital-treated minimal-trauma rib fractures in elderly Finns: long-term trends and projections for the future. Osteoporos Int 2004, 15(8):649-653.
21. Palvanen M, Kannus P, Niemi S, Parkkari J, Vuori I: Epidemiology of minimal trauma rib fractures in the elderly. Calcif Tissue Int 1998, 62(3):274-277.
22. Hauptverband der österreichischen Sozialversicherungsträger: Erstattungskodex-EKO. 1030th edition. Wien: Hauptverband der österreichischen Sozialversicherungsträger; 2008.
23. Statistik Austria: Arbeitskostenerhebungen 2008. Vienna: Statistik Austria; 2008.
24. Miller RE, Blair PB: Input-output Analysis. Foundations and Extentions. New York: Cambridge University Press; 2010.
25. Obermayer U, Mayer-Schulz M, Stefanits J: Invaliditätspensionen. In Sozialbericht 2007 - 2008 - Ressortaktivitäten und sozialpolitische Analysen. Vienna: Bundesministerium für Soziales und Konsumentenschutz; 2008.
26. Borgström F, Sobocki P, Ström O, Jönsson B: The societal burden of osteoporosis in Sweden. Bone 2007, 40(6):1602-1609.
27. Borgström F, Zethraeus N, Johnell O, Lidgren L, Ponzer S, Svensson O, et al: Costs and quality of life associated with osteoporosis-related fractures in Sweden. Osteoporos Int 2006, 17(5):637-650.
28. Pike MM, Barnes MA, Barron RW: The role of illustrations in children's inferential comprehension. J Exp Child Psychol 2010, 105(3):243-255.
29. Bouza C, López T, Palma M, Amate JM: Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry. Osteoporos Int 2007, 18(5):649-657.
30. Zethraeus N, Strömberg L, Jönsson B, Svensson O, Ohlén G: The cost of a hip fracture. Estimates for 1,709 patients in Sweden. Acta Orthop Scand 1997, 68(1):13-17.
31. Johnell O, Gullberg B, Kanis JA: The hospital burden of vertebral fracture in Europe: a study of national register sources. Osteoporos Int 1997, 7(2):138-144.
32. Johnell O, Kanis JA, Jonsson B, Oden A, Johansson H, De Laet C: The burden of hospitalised fractures in Sweden. Osteoporos Int 2005, 16(2):222-228.
33. Cooper C, Campion G, Melton LJ: Hip fractures in the elderly: a world-wide projection. Osteoporos Int 1992, 2(6):285-289.
34. Riggs BL, Hartmann LC: Selective estrogen-receptor modulators - mechanisms of action and application to clinical practice. N Engl J Med 2003, 348(7):618-629.
35. Cummings SR, San Martin J, McClung MR, Siris ES, Eastell R, Reid IR, et al: Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 2009, 361(8):756-765.
36. Dimai HP, Pietschmann P, Resch H, Preisinger E, Fahrleitner-Pammer A, Dobnig H, et al: Austrian guidance for the pharmacological treatment of osteoporosis in postmenopausal women-update 2009. Wien Med Wochenschr Suppl 2009, 122:1-34.
37. Seeman E, Compston J, Adachi J, Brandi ML, Cooper C, Dawson-Hughes B, et al: Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int 2007, 18(6):711-719.
38. Silverman SL, Gold DT, Cramer JA: Reduced fracture rates observed only in patients with proper persistence and compliance with bisphosphonate therapies. South Med J 2007, 100(12):1214-1218.
39. Reginster J: Adherence and persistence: impact on outcomes and health care resources. Bone 2006, 38(2 Suppl 2):S18-S21.
40. Pietschmann P, Azizi-Semrad U, Pils K, Fahrleitner-Pammer A, Resch H, Dobnig H: Pharmacologic undertreatment of osteoporosis in Austrian nursing homes and senior's residences. Wien Klin Wochenschr 2010, 122(17-18):532-537.